Filing Details

Accession Number:
0000903423-18-000616
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-19 19:22:22
Reporting Period:
2018-11-16
Accepted Time:
2018-11-19 19:22:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1578845 Allergan Plc AGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1269428 M Matthew Walsh Clonshaugh Business And Technology Park
Dublin L2 D17 E400
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.0001 Acquisiton 2018-11-16 1,000 $157.00 26,416 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes restricted shares issued pursuant to the Amended and Restated Allergan, Inc. 2011 Incentive Award Plan.